Published in Atherosclerosis on December 29, 2004
Coenzyme Q10: is there a clinical role and a case for measurement? Clin Biochem Rev (2008) 0.95
Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure. Heart (2006) 0.92
Impact of adherence to statins on chronic heart failure in primary prevention. Br J Clin Pharmacol (2008) 0.91
Effect of atorvastatin in patients with chronic heart failure - insights from randomized clinical trials. Arch Med Sci (2010) 0.88
Statins in the treatment of chronic heart failure: a systematic review. PLoS Med (2006) 0.85
Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives. Heart Fail Rev (2006) 0.84
Atorvastatin protects against cerebral ischemia/reperfusion injury through anti-inflammatory and antioxidant effects. Neural Regen Res (2014) 0.84
Genetic evidence for the requirement of the endocytic pathway in the uptake of coenzyme Q6 in Saccharomyces cerevisiae. Biochim Biophys Acta (2009) 0.82
The case for statin therapy in chronic heart failure. Clin Res Cardiol (2007) 0.81
Should a statin be prescribed to every patient with heart failure? Heart Fail Rev (2007) 0.76
Coenzyme Q10, carotenoid, tocopherol, and retinol levels in cord plasma from multiethnic subjects in Hawaii. Free Radic Res (2013) 0.76
A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet (2011) 5.61
N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial. J Am Coll Cardiol (2009) 4.00
Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int (2010) 3.37
2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol (2012) 3.15
Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int (2011) 3.05
Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial. Ann Surg (2008) 2.50
Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA (2012) 2.27
A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22
Holmium laser enucleation of the prostate: results at 6 years. Eur Urol (2007) 2.07
Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. J Am Coll Cardiol (2005) 2.05
Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol (2003) 1.80
Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol (2010) 1.77
A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Disord (2010) 1.72
Urocortin 2 infusion in human heart failure. Eur Heart J (2007) 1.67
The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev (2007) 1.62
Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction. Eur Heart J (2008) 1.58
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int (2010) 1.54
Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care (2010) 1.50
Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther (2009) 1.49
PHARMAC's funding of 9 weeks Herceptin: many assumptions in a high-risk decision. N Z Med J (2007) 1.48
How paraproteins can affect laboratory assays: spurious results and biological effects. Pathology (2010) 1.45
Effectiveness of computerised cognitive behaviour therapy for anxiety disorders in secondary care. Aust N Z J Psychiatry (2012) 1.44
Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int (2011) 1.44
Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol (2007) 1.43
Prospective validation of cerebrospinal fluid bilirubin in suspected subarachnoid haemorrhage. Ann Clin Biochem (2007) 1.40
Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation (2010) 1.36
Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol (2008) 1.35
Comprehensive undergraduate medical assessments improve prediction of clinical performance. Med Educ (2004) 1.35
Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol (2007) 1.31
Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study). Am J Cardiol (2005) 1.31
Evaluation of trial outcomes in acute kidney injury by creatinine modeling. Clin J Am Soc Nephrol (2009) 1.29
Seasonality of birth and onset of clinical disease in children and adolescents (0-19 years) with type 1 diabetes mellitus in Canterbury, New Zealand. J Pediatr Endocrinol Metab (2002) 1.24
Contamination of Qiagen DNA extraction kits with Legionella DNA. J Clin Microbiol (2003) 1.22
The effect of ambient air pollution on respiratory health of school children: a panel study. Environ Health (2008) 1.18
Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev (2008) 1.17
Double complex mutations involving F8 and FUNDC2 caused by distinct break-induced replication. Hum Mutat (2007) 1.15
Four hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients. Crit Care (2012) 1.13
Trimethylaminuria: causes and diagnosis of a socially distressing condition. Clin Biochem Rev (2011) 1.12
Incidence of type 1 diabetes mellitus diagnosed before age 20 years in Canterbury, New Zealand over the last 30 years. J Pediatr Endocrinol Metab (2002) 1.10
Mutant fibrinogen cleared from the endoplasmic reticulum via endoplasmic reticulum-associated protein degradation and autophagy: an explanation for liver disease. Am J Pathol (2006) 1.09
Detection of factor VIII gene mutations by high-resolution melting analysis. Clin Chem (2007) 1.08
The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem (2012) 1.06
Vitamin D receptor genotypes influence the success of calcitriol therapy for recurrent vertebral fracture in osteoporosis. Pharmacogenet Genomics (2005) 1.05
The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf) (2002) 1.04
Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis (2007) 1.02
Objectivity in objective structured clinical examinations: checklists are no substitute for examiner commitment. Acad Med (2003) 1.00
Self-management plans in the primary care of patients with chronic obstructive pulmonary disease. Respirology (2006) 0.99
Randomized trial comparing holmium laser enucleation of prostate with plasmakinetic enucleation of prostate for treatment of benign prostatic hyperplasia. Urology (2006) 0.99
Urocortin 2 infusion in healthy humans: hemodynamic, neurohormonal, and renal responses. J Am Coll Cardiol (2007) 0.98
Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-up. Diabetes Res Clin Pract (2008) 0.97
Inflammatory biomarkers for predicting cardiovascular disease. Clin Biochem (2013) 0.97
Plasma lipids and betaine are related in an acute coronary syndrome cohort. PLoS One (2011) 0.97
Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure. Circulation (2006) 0.96
Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism (2005) 0.96
Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol (2002) 0.96
Coenzyme Q10: is there a clinical role and a case for measurement? Clin Biochem Rev (2008) 0.95
Preventing a Cardiovascular Disease Epidemic among Indigenous Populations through Lifestyle Changes. Int J Prev Med (2012) 0.95
The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression. J Affect Disord (2009) 0.94
Novel fibrinogen gamma375 Arg-->Trp mutation (fibrinogen aguadilla) causes hepatic endoplasmic reticulum storage and hypofibrinogenemia. Hepatology (2002) 0.94
Patient predictors of response to cognitive behaviour therapy and interpersonal psychotherapy in a randomised clinical trial for depression. J Affect Disord (2010) 0.94
Impact of prandial status on the comparison of capillary glucose meter and venous plasma glucose measurements in healthy volunteers. Ann Clin Biochem (2012) 0.93
Effects of orange juice and proline betaine on glycine betaine and homocysteine in healthy male subjects. Eur J Nutr (2007) 0.93
Use of fully denaturing HPLC for UGT1A1 genotyping in Gilbert syndrome. Clin Chem (2005) 0.92
Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects. Am J Clin Nutr (2008) 0.92
Urocortin-1 infusion in normal humans. J Clin Endocrinol Metab (2004) 0.92
Proteome-wide analysis and CXCL4 in systemic sclerosis. N Engl J Med (2014) 0.92
Dietary salt levels affect salt preference and learning in larval Drosophila. PLoS One (2011) 0.91
Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract formulation. Phytother Res (2008) 0.91
Plasma retinol-binding protein is not a marker of insulin resistance in overweight subjects: a three year longitudinal study. Clin Biochem (2008) 0.91
A glucose meter evaluation co-designed with both health professional and consumer input. N Z Med J (2013) 0.90
Assessments of arterial stiffness and endothelial function using pulse wave analysis. Int J Vasc Med (2012) 0.90
Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem (2004) 0.90
Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenet Genomics (2008) 0.90
A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence. BJU Int (2009) 0.90
A model of non-elemental olfactory learning in Drosophila. J Comput Neurosci (2011) 0.90
Betaine and secondary events in an acute coronary syndrome cohort. PLoS One (2012) 0.90
Sympatho-vagal responses in patients with sleep and typical vasovagal syncope. Clin Sci (Lond) (2009) 0.89